A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle

por Gudde, Anke E. E. G., González-Barriga, Anchel, van den Broek, Walther J. A. A., Wieringa, Bé, Wansink, Derick G.
Publicado 2016

CRISPR/Cas9-Induced (CTG⋅CAG)(n) Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing

por van Agtmaal, Ellen L., André, Laurène M., Willemse, Marieke, Cumming, Sarah A., van Kessel, Ingeborg D.G., van den Broek, Walther J.A.A., Gourdon, Geneviève, Furling, Denis, Mouly, Vincent, Monckton, Darren G., Wansink, Derick G., Wieringa, Bé
Publicado 2017

Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy

por González-Barriga, Anchel, Kranzen, Julia, Croes, Huib J. E., Bijl, Suzanne, van den Broek, Walther J. A. A., van Kessel, Ingeborg D. G., van Engelen, Baziel G. M., van Deutekom, Judith C. T., Wieringa, Bé, Mulders, Susan A. M., Wansink, Derick G.
Publicado 2015